{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:39:14Z","timestamp":1773733154311,"version":"3.50.1"},"reference-count":40,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,11,1]]},"abstract":"<jats:p>We have shown that in situ estrogen synthesized in leiomyoma of the uterus plays a possible role in the promotion of leiomyoma cell growth via an autocrine\/paracrine mechanism. In the present study, we demonstrated that leuprorelin acetate, a GnRH agonist widely used for treatment of uterine leiomyoma by down-regulation of pituitary-ovarian function, suppressed the expression of aromatase P450 (an estrogen synthetase) in leiomyoma cells. Given the role of in situ estrogen in leiomyoma cell growth, the inhibition of in situ estrogen synthesis may play a role in GnRH agonist-induced rapid regression of leiomyomas. Quantitative RT-PCR revealed that in women receiving no medication uterine leiomyomas express aromatase P450 mRNA at levels 20 times higher than that in the surrounding myometrium. Leuprorelin acetate treatment (1.88 mg every 4 wk, sc injection) for 12\u201324 wk reduced the expression of aromatase P450 mRNA in leiomyoma tissue as well as in the myometrium, to approximately one tenth of that in the myometrium of untreated women. Suppression of aromatase P450 expression was also demonstrated by Western blot analysis and aromatase activity assay of microsomal fractions prepared from leiomyomas. On the other hand, no differences in the levels of activity and mRNA of aromatase P450 were observed between leiomyoma cells obtained from women treated with and without leuprorelin acetate injections when cells were cultured ex vivo and stimulated by various combinations of stimulants such as dexamethasone + IL-1\u03b2. The addition of various concentrations of E2 did not affect the aromatase activity of leiomyoma cells, suggesting that deprivation of circulating (ovarian) estrogen is not a cause of decreased expression of aromatase during leuprorelin acetate therapy. On the other hand, 8-d treatment with leuprorelin acetate (100 nmol\/liter) reduced dexamethasone + IL-1\u03b2-induced activity and a mRNA level of aromatase by 28% and 42%, respectively. These results indicated that leuprorelin acetate inhibits the expression of aromatase P450 in leiomyoma cells, which contributes to the rapid regression of leiomyoma during leuprorelin acetate therapy.<\/jats:p>","DOI":"10.1210\/jcem.86.11.8026","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:06:35Z","timestamp":1389200795000},"page":"5405-5411","source":"Crossref","is-referenced-by-count":25,"title":["Inhibition of in Situ Expression of Aromatase P450 in Leiomyoma of the Uterus by Leuprorelin Acetate"],"prefix":"10.1210","volume":"86","author":[{"given":"Makio","family":"Shozu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Kanazawa University, Kanazawa 920-0934, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sumitani","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Kanazawa University, Kanazawa 920-0934, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Segawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Kanazawa University, Kanazawa 920-0934, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hei-Juan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Kanazawa University, Kanazawa 920-0934, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Kanazawa University, Kanazawa 920-0934, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Kanazawa University, Kanazawa 920-0934, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071621280922900_R1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/humrep\/14.suppl_1.194","article-title":"Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues","author":"Ortmann","year":"1999","journal-title":"Hum Reprod 14(Suppl 1):"},{"key":"2020071621280922900_R2","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1073\/pnas.96.5.2361","article-title":"Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity.","volume":"96","author":"Palyi","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071621280922900_R3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00662399","article-title":"Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters.","volume":"25","author":"Baumann","year":"1993","journal-title":"Breast Cancer Res Treat"},{"key":"2020071621280922900_R4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-9378(93)90630-2","article-title":"Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma.","volume":"169","author":"Ohno","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"2020071621280922900_R5","first-page":"50","article-title":"Gonadotropin-releasing hormone has a biphasic action on aromatase activity through protein kinase C in granulosa cells.","volume":"38","author":"Imai","year":"1993","journal-title":"Int J Fertil Menopausal Stud"},{"key":"2020071621280922900_R6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-5347(05)67947-5","article-title":"High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers.","volume":"163","author":"Halmos","year":"2000","journal-title":"J Urol"},{"key":"2020071621280922900_R7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/000456329403100604","article-title":"Expression of gonadotropin-releasing hormone receptor in human epithelial ovarian carcinoma.","volume":"31","author":"Imai","year":"1994","journal-title":"Ann Clin Biochem"},{"key":"2020071621280922900_R8","first-page":"580","article-title":"Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion.","volume":"80","author":"Lin","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071621280922900_R9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/endo.141.1.7250","article-title":"Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium.","volume":"141","author":"Kang","year":"2000","journal-title":"Endocrinology"},{"key":"2020071621280922900_R10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-642-59587-5_7","article-title":"Primary and salvage therapy with LH-RH analogues in ovarian cancer.","volume":"153","author":"Emons","year":"2000","journal-title":"Recent Results Cancer Res"},{"key":"2020071621280922900_R11","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1067\/mob.2000.103939","article-title":"Effects of leuprolide acetate on low-grade endometrial stromal sarcoma.","volume":"182","author":"Mesia","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"2020071621280922900_R12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/oxfordjournals.humrep.a138714","article-title":"The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers.","volume":"9","author":"Emons","year":"1994","journal-title":"Hum Reprod"},{"key":"2020071621280922900_R13","first-page":"5133","article-title":"Role of mitogen-activated protein kinase\/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.","volume":"59","author":"Kimura","year":"1999","journal-title":"Cancer Res"},{"key":"2020071621280922900_R14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/molehr\/3.2.91","article-title":"Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues.","volume":"3","author":"Kobayashi","year":"1997","journal-title":"Mol Hum Reprod"},{"key":"2020071621280922900_R15","first-page":"1341","article-title":"Advanced ovarian carcinoma: response to the agonist D-Trp-6-LHRH [Letter].","volume":"69","author":"Parmar","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"2020071621280922900_R16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/bmj.296.6631.1229","article-title":"Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.","volume":"296","author":"Parmar","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2020071621280922900_R17","first-page":"531","article-title":"Therapy of advanced ovarian cancer with D-Trp-6-LH-RH (decapeptyl) microcapsules.","volume":"42","author":"Parmar","year":"1988","journal-title":"Biomed Pharmacother"},{"key":"2020071621280922900_R18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0028-2243(89)90195-0","article-title":"Some observations on the effect of a GnRH analog in ovarian cancer.","volume":"32","author":"Jager","year":"1989","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020071621280922900_R19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.1989.7.1.115","article-title":"Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancer.","volume":"7","author":"Kavanagh","year":"1989","journal-title":"J Clin Oncol"},{"key":"2020071621280922900_R20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/0002-9378(89)90669-8","article-title":"Treatment of advanced refractory ovarian carcinoma with a gonadotropin-releasing hormone analogue.","volume":"161","author":"Bruckner","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"2020071621280922900_R21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/09513599209024990","article-title":"GnRH agonist analog therapy in advanced\/recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment","volume":"6","author":"Kauppila","year":"1992","journal-title":"Gynecol Endocrinol"},{"key":"2020071621280922900_R22","first-page":"3627","article-title":"Combined treatment with goserelin and tamoxifen in patients with advanced chemotherapy resistant ovarian cancer.","volume":"19","author":"Hofstra","year":"1999","journal-title":"Anticancer Res"},{"key":"2020071621280922900_R23","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0002-9378(92)91707-H","article-title":"Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.","volume":"166","author":"Adamson","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2020071621280922900_R24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00125480-199803000-00054","article-title":"Effects of leuprolide acetate on treatment of leiomyomata\u2013clues to mechanisms of action.","volume":"5","author":"Demopoulos","year":"1998","journal-title":"Adv Anat Pathol"},{"key":"2020071621280922900_R25","first-page":"736","article-title":"Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture.","volume":"78","author":"Bulun","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071621280922900_R26","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/endo.141.10.7719","article-title":"In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine\/intracrine mechanism.","volume":"141","author":"Sumitani","year":"2000","journal-title":"Endocrinology"},{"key":"2020071621280922900_R27","first-page":"35","article-title":"Clinical usefulness of GnRH agonist therapy for premenopausal women with uterine leiomyoma.","volume":"47","author":"Kurose","year":"1995","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"key":"2020071621280922900_R28","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1210\/endo.138.12.5562","article-title":"Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene.","volume":"138","author":"Shozu","year":"1997","journal-title":"Endocrinology"},{"key":"2020071621280922900_R29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0303-7207(98)00069-0","article-title":"Aromatase expression of human osteoblast-like cells.","volume":"139","author":"Shozu","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"2020071621280922900_R30","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1210\/endo-120-6-2220","article-title":"Effect of relaxin on aromatase activity in human endometrial stromal cells.","volume":"120","author":"Tseng","year":"1987","journal-title":"Endocrinology"},{"key":"2020071621280922900_R31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0303-7207(95)03512-6","article-title":"Expression and regulation of aromatase cytochrome P450 in THP 1 human myeloid leukaemia cells.","volume":"110","author":"Jakob","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"2020071621280922900_R32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0002-9378(90)90667-V","article-title":"Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.","volume":"163","author":"Friedman","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"2020071621280922900_R33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1447-0756.2000.tb01334.x","article-title":"A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.","volume":"26","author":"Takeuchi","year":"2000","journal-title":"J Obstet Gynaecol Res"},{"key":"2020071621280922900_R34","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/oxfordjournals.humrep.a138762","article-title":"Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin \u201cadd-back\u201d for 2 years.","volume":"9","author":"Friedman","year":"1994","journal-title":"Hum Reprod"},{"key":"2020071621280922900_R35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00215887","article-title":"Uterine smooth muscle cells in primary culture. Alterations in fine structure, cytoskeletal organization and growth characteristics.","volume":"246","author":"Palmberg","year":"1986","journal-title":"Cell Tissue Res"},{"key":"2020071621280922900_R36","first-page":"3222","article-title":"Suppression of transforming growth factor-\u03b2 (TGF \u03b2) and TGF \u03b2 receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.","volume":"81","author":"Dou","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071621280922900_R37","first-page":"3215","article-title":"Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.","volume":"81","author":"Chegini","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071621280922900_R38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0960-0760(97)00189-1","article-title":"Effects of LHRH-analogues on mitogenic signal transduction in cancer cells.","volume":"65","author":"Emons","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 14","key":"2020071621280922900_R39","first-page":"18","article-title":"Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids","volume":"103","author":"Thomas","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"2020071621280922900_R40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/09513599909167584","article-title":"Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata.","volume":"13","author":"Nakayama","year":"1999","journal-title":"Gynecol Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/86\/11\/5405\/9170363\/jcem5405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/86\/11\/5405\/9170363\/jcem5405.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T08:48:40Z","timestamp":1594975720000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/86\/11\/5405\/2849509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.86.11.8026","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11,1]]}}}